Evaluation of an Intravitreal Rho-Associated Kinase Inhibitor Depot Formulation in a Rat Model of Diabetic Retinopathy
Rho-associated kinase (ROCK) activation was shown to contribute to microvascular closure, retinal hypoxia, and to retinal pigment epithelium (RPE) barrier disruption in a rat model of diabetic retinopathy. Fasudil, a clinically approved ROCK inhibitor, improved retinal perfusion and reduced edema in...
Saved in:
Main Authors: | Cecile Lebon (Author), Heike Neubauer (Author), Marianne Berdugo (Author), Kimberley Delaunay (Author), Elke Markert (Author), Kolja Becker (Author), Katja S. Baum-Kroker (Author), Jürgen Prestle (Author), Holger Fuchs (Author), Remko A. Bakker (Author), Francine Behar-Cohen (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Term Oral Treatment with Non-Hypoglycemic Dose of Glibenclamide Reduces Diabetic Retinopathy Damage in the Goto-KakizakiRat Model
by: Marianne Berdugo, et al.
Published: (2021) -
Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
by: Raphael Mietzner, et al.
Published: (2020) -
Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity
by: Caifeng Gao, et al.
Published: (2023) -
Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
by: Wei Loon Ng, et al.
Published: (2024) -
Aggressive Posterior Retinopathy of Prematurity: Long-Term Outcomes Following Intravitreal Bevacizumab
by: Ameay V. Naravane, et al.
Published: (2022)